SCHEMBL171074

SCHEMBL171074

COc1ccc(C(C)O)nc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35
NQO2 P16083 1/20 0.34
CYP2D6 P10635 1/20 0.34
ADRA2A P08913 1/20 0.34
ADRA1A P35348 1/20 0.34
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ACHE P22303 1/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31003128 1.00 KDM4E (0.49) KDM4EL3MBTL1PDE4APDE4BPDE4C
SCHEMBL172434 0.84 KDM4E (0.47) KDM4EL3MBTL1ALDH1A1TSHRNQO2
SCHEMBL10200960 0.79 PDE4A (0.39) KDM4EPDE4APDE4BPDE4CPDE4D
SCHEMBL31003115 0.75 NOS3 (0.43) KDM4EHPGDHSD17B10KMT2A
SCHEMBL24122998 0.72 RAB9A (0.35) KDM4EALDH1A1NQO2MAPTSMN1; SMN2
SCHEMBL30374033 0.72 PDE2A (0.33)
SCHEMBL588457 0.72 PDE2A (0.33)
SCHEMBL30325993 0.72 RAB9A (0.35) KDM4EALDH1A1NQO2MAPTSMN1; SMN2
SCHEMBL26937900 0.72 SLC10A2 (0.38) KDM4EL3MBTL1PDE4APDE4BPDE4C
SCHEMBL7849024 0.70 KDM4E (0.53) KDM4EL3MBTL1ALDH1A1TSHRNQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEONE MEDICINES I GMBH (CH) 2025-11-13 US disclosed
EP-1979331-B1 TRISUBSTITUTED AMINE COMPOUNDS AS INHIBITORS OF -CHOLESTERYL ESTER TRANSFER PROTEIN CETP MITSUBISHI TANABE PHARMA CORP (JP) 2012-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES DGKG, DGKA, DGKK KDM4E 2066/4885L3MBTL1 4317/4885PDE4A 1840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.